Democratic Senator Ron Wyden has accused a senior official at the United States Department of Justice of preventing the release of a key document tied to a secret investigation into Jeffrey Epstein for drug trafficking and prostitution.
According to Wyden, Deputy Attorney General Todd Blanche blocked the disclosure of an unredacted 2015 memorandum prepared by the Organized Crime Drug Enforcement Task Forces, a federal body responsible for coordinating complex drug trafficking and money laundering investigations.
Blanche denied the allegations on social media, stating that “no one is blocking anything” and asserting that the document is available to members of Congress in a secure reading room. He also criticized Wyden for not accessing it there.
A broad and sensitive federal investigation
Previously released information indicates that the heavily redacted memorandum—part of millions of documents made public in January—confirms that Epstein had been under investigation by the Drug Enforcement Administration (DEA) for at least five years.
In a letter to Blanche, Wyden said Senate investigators had been told the DEA was prepared to provide an unredacted version of the memo before an alleged intervention by the Justice Department in recent weeks. He described the situation as “deeply troubling.”
The senator further claimed that authorities had “ample evidence” suggesting Epstein was involved in drug trafficking and may have administered substances to his victims, including minors, to facilitate abuse.
Synthetic drugs and suspicious transfers
The document reveals that the investigation targeted Epstein along with 14 other individuals suspected of engaging in financial transactions linked to illegal activities. Sources say investigators focused on so-called “club drugs,” including ketamine, ecstasy (MDMA), and GHB.
The memo references suspicious activities between New York City and the U.S. Virgin Islands, involving financial transfers potentially connected to drug trafficking or prostitution. Classified as “law enforcement sensitive,” it conceals the identities of the other individuals involved.
According to a law enforcement source, the involvement of a federal data fusion center suggests the case was considered “significant.” Opening a DEA investigation typically requires a clear connection to drug-related activity.
Continued opacity around the case
A recent Freedom of Information Act (FOIA) request seeking additional details was denied by the DEA, which cited the risk of interfering with ongoing enforcement proceedings.
Sources also indicated that the document may contain highly sensitive information, including details of active operations or the identities of confidential informants.
A controversial legal history
Jeffrey Epstein was arrested in July 2019 as part of a separate investigation conducted by federal prosecutors in New York. Prosecutors involved in that case were reportedly unaware of the earlier DEA probe.
Weeks later, Epstein was found dead in his jail cell. His death was officially ruled a suicide.
The case renews questions about transparency within U.S. authorities in handling Epstein-related investigations, as the broader implications of his network continue to fuel political tensions.
With CBS News
#Iran #Israel #USA #US_Israel_war_against_Iran #RonWyden #ToddBlanche #OrganizedCrimeDrugEnforcementTaskForces